Opportunity Information: Apply for CDC RFA OE17 17020401SUPP20
This CDC grant opportunity, titled "Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease" (CDC-RFA-OE-17-1702), is designed to strengthen the United States public health system's ability to address primary immunodeficiency (PID) diseases by expanding both physician education and broader public health awareness. The central idea is to improve how quickly PID is recognized in clinical settings and, as a result, improve health outcomes for people living with primary immunodeficiency diseases. Rather than focusing on direct clinical services, the program emphasizes education, communication, and dissemination of credible, evidence-based information so that more patients are identified earlier and connected to appropriate care.
The main objective is national-level dissemination of educational information aimed at a wide mix of audiences who influence recognition, diagnosis, and management of PID. These audiences include public and private health care providers, educators, third-party payers, families impacted by PID, and other stakeholders who can help reduce delays in diagnosis and improve long-term outcomes. In practice, this means the funded effort is expected to create and spread educational materials and messaging that help clinicians and decision-makers recognize warning signs, understand diagnostic pathways, and appreciate the public health importance of PID. The broader public awareness component is intended to help families and communities better understand PID and support timely medical evaluation when symptoms suggest immune dysfunction.
The opportunity is administered within the Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC), specifically associated with the Office of Genomics and Precision Public Health (OGPPH) under the Deputy Director for Public Health Science and Surveillance (DDPHSS). This placement signals that the work is meant to be grounded in evidence-based public health practice and aligned with CDC priorities such as advancing evidence-based health policies, preventing illness and premature death, and supporting state, tribal, and local health departments. The program also connects to CDC efforts to generate reliable information that can inform policy and public health programs in genomics and precision public health, with an emphasis on improving health care delivery and helping contain costs through earlier and more accurate identification of disease.
The grant explicitly aligns with Healthy People 2020/2030 priorities, particularly in areas related to education, community-based programs, and health communication. By concentrating resources on educational and communication strategies where genomics and related approaches can enhance prevention and earlier detection, the program supports broader national goals around prevention, wellness, and higher-value, safer, and more effective health care. The underlying public health logic is that earlier recognition of PID can reduce preventable complications, avoid repeated ineffective treatments, and improve quality of life, while also potentially lowering downstream health system costs.
From an administrative standpoint, this is a discretionary grant funding opportunity (CFDA 93.980) with eligibility listed as unrestricted, meaning a wide range of entity types may apply as long as they meet any additional criteria described in the full announcement. The opportunity anticipated a single award (ExpectedAwards: 1) with an award ceiling of $5,607,500. The posting indicates the opportunity was created June 4, 2020, with an original closing date of July 10, 2020, and applications required electronic submission by 11:59 p.m. Eastern Time on the due date.Apply for CDC RFA OE17 17020401SUPP20
- The Department of Health and Human Services, Centers for Disease Control - CSELS in the health sector is offering a public funding opportunity titled "Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.980.
- This funding opportunity was created on Jun 04, 2020.
- Applicants must submit their applications by Jul 10, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,607,500.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and number of this CDC grant opportunity?
The opportunity is titled "Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease" and is identified as CDC-RFA-OE-17-1702.
What is the main purpose of this grant?
The grant is designed to strengthen the United States public health system's ability to address primary immunodeficiency (PID) diseases by expanding physician education and broader public health awareness. The overall goal is to improve how quickly PID is recognized in clinical settings and, in turn, improve outcomes for people living with PID.
Does this program fund direct clinical care or medical services?
No. The description emphasizes education, communication, and dissemination of credible, evidence-based information rather than direct clinical services.
What public health problem is this grant trying to address?
The program aims to reduce delays in recognizing and diagnosing primary immunodeficiency diseases. Earlier recognition is expected to help connect people to appropriate care sooner, reduce preventable complications, and improve long-term outcomes.
What kinds of activities are expected under this award?
The funded effort is expected to focus on national-level dissemination of educational information. This includes developing and spreading educational materials and messaging that help relevant audiences recognize warning signs of PID, understand diagnostic pathways, and understand the public health importance of PID.
Who are the intended audiences for the educational and awareness efforts?
The opportunity targets a wide mix of audiences involved in recognition, diagnosis, and management of PID, including public and private health care providers, educators, third-party payers, families impacted by PID, and other stakeholders who can influence timely diagnosis and better outcomes.
Why does the program focus on education and communication?
The program's underlying logic is that credible, evidence-based education and communication can lead to earlier identification of PID, which can reduce repeated ineffective treatments, prevent complications, improve quality of life, and potentially lower downstream health system costs.
What is meant by "national-level dissemination" in this opportunity?
Based on the description, the primary objective is to distribute educational information broadly across the United States to reach multiple stakeholder groups that influence PID recognition and diagnosis.
Which federal agency administers this grant?
This is a Department of Health and Human Services (HHS) opportunity administered through the Centers for Disease Control and Prevention (CDC).
Where within CDC is this opportunity located?
The opportunity is associated with the Office of Genomics and Precision Public Health (OGPPH) under the Deputy Director for Public Health Science and Surveillance (DDPHSS).
How does the opportunity connect to genomics and precision public health?
The placement within OGPPH indicates the work is expected to be grounded in evidence-based public health practice and connected to CDC efforts that generate reliable information to inform policy and public health programs in genomics and precision public health, with an emphasis on improving health care delivery and containing costs through earlier and more accurate identification of disease.
How does this grant align with national health priorities?
The grant explicitly aligns with Healthy People 2020/2030 priorities, particularly those related to education, community-based programs, and health communication. It also supports broader goals around prevention, wellness, and higher-value, safer, and more effective health care.
What type of funding mechanism is this?
It is a discretionary grant funding opportunity.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.980.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning a wide range of entity types may apply, as long as they meet any additional criteria described in the full announcement.
How many awards were anticipated?
The opportunity anticipated a single award (ExpectedAwards: 1).
What is the maximum funding amount available under this opportunity?
The award ceiling is listed as $5,607,500.
When was this opportunity posted?
The posting indicates the opportunity was created on June 4, 2020.
What was the application due date?
The original closing date was July 10, 2020.
What time were applications due on the closing date, and how were they submitted?
Applications required electronic submission by 11:59 p.m. Eastern Time on the due date.
What is the intended outcome of improving awareness among families and communities?
The public awareness component is intended to help families and communities better understand PID and support timely medical evaluation when symptoms suggest immune dysfunction.
What is the intended outcome of improving education among health care providers and decision-makers?
The provider-focused education aims to improve recognition of PID warning signs and diagnostic pathways, which is expected to reduce diagnostic delays and improve long-term outcomes.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Ecosystem Studies Unit, Colorado Plateau CESU
Previous opportunity: Exposing Russian Health Disinformation
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA OE17 17020401SUPP20
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA OE17 17020401SUPP20) also looked into and applied for these:
| Funding Opportunity |
|---|
| Enhancing Public Health Laboratory Capabilities and Increasing Capacity Apply for CDC RFA OE20 20010101SUPP20 Funding Number: CDC RFA OE20 20010101SUPP20 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $100,000,000 |
| Pregnancy Prevention Research Grants Apply for PA PHE 20 002 Funding Number: PA PHE 20 002 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,500,000 |
| Announcement of Anticipated Availability of Funds for Research to Practice Center Grants for Adolescent Health Promotion in Order to Prevent Teenage Pregnancy Apply for PA PHE 20 001 Funding Number: PA PHE 20 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,200,000 |
| Announcement of the Availability of Funds for Research on Research Integrity Apply for IR ORI 20 001 Funding Number: IR ORI 20 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $150,000 |
| Announcement of the Availability of Funds for Conferences on Research Integrity Apply for IR ORI 20 002 Funding Number: IR ORI 20 002 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $50,000 |
| Announcement of the Availability of Funds for Research Integrity Program Development and Evaluation Apply for IR ORI 20 003 Funding Number: IR ORI 20 003 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $100,000 |
| Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program Apply for HRSA 21 055 Funding Number: HRSA 21 055 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rural Communities Opioid Response Program – Neonatal Abstinence Syndrome (RCORP-NAS) Apply for HRSA 20 106 Funding Number: HRSA 20 106 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 21 023 Funding Number: RFA AG 21 023 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $100,000 |
| Advancing Ethiopia's Capacity to meet International Health Regulations requirements Apply for CDC RFA GH20 2112 Funding Number: CDC RFA GH20 2112 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 21 002 Funding Number: HRSA 21 002 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Tribal Injury Prevention Cooperative Agreement Program Apply for HHS 2020 IHS IPP 0001 Funding Number: HHS 2020 IHS IPP 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $125,000 |
| Service Area Competition-Additional Area: Newark, NJ Apply for HRSA 21 084 Funding Number: HRSA 21 084 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 21 003 Funding Number: HRSA 21 003 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Tribal Management Grant Program Apply for HHS 2020 IHS TDM 0001 Funding Number: HHS 2020 IHS TDM 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $150,000 |
| Service Area Competition Apply for HRSA 21 004 Funding Number: HRSA 21 004 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Women’s Preventive Services Initiative Apply for HRSA 21 045 Funding Number: HRSA 21 045 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $950,000 |
| Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) Apply for RFA AI 20 043 Funding Number: RFA AI 20 043 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Healthy Tomorrows Partnership for Children Program (HTPCP) Apply for HRSA 21 031 Funding Number: HRSA 21 031 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $50,000 |
| Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats Apply for CDC RFA CK20 2003 Funding Number: CDC RFA CK20 2003 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA OE17 17020401SUPP20", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.